Tumor lysis syndrome in a patient with metastatic, androgen independent prostate cancer

International Journal of Urology

Volumn 12, Issue 11, 2005, Pages 1012-1013

  Wright, Jonathan L ^a   Lin, Daniel W ^a   Dewan, Puneet ^b   Montgomery, R Bruce ^b,c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

Hormone refractory; Prostate cancer; Tumor lysis syndrome

Indexed keywords

ANDROGEN; ANTIBIOTIC AGENT; CYTOKINE; ESTRAMUSTINE; PACLITAXEL; PROSTATE SPECIFIC ANTIGEN;

ADENOCARCINOMA; ADULT; ANEMIA; ARTICLE; BIOPSY; BONE METASTASIS; CANCER CHEMOTHERAPY; CASE REPORT; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISSEMINATED INTRAVASCULAR CLOTTING; FEBRILE NEUTROPENIA; HEMODIALYSIS; HUMAN; HUMAN TISSUE; HYPOVOLEMIA; INTERSTITIAL NEPHRITIS; KIDNEY FAILURE; LABORATORY TEST; LIVER METASTASIS; LYMPHADENOPATHY; MALE; METASTASIS; MONOTHERAPY; ORCHIECTOMY; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; STENT; THROMBOCYTOPENIA; TUMOR LYSIS SYNDROME;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BONE MARROW NEOPLASMS; BONE NEOPLASMS; HEMATURIA; HUMANS; HYDRONEPHROSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PACLITAXEL; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RENAL DIALYSIS; RENAL INSUFFICIENCY; TUMOR LYSIS SYNDROME;

EID: 30944463971     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2005.01196.x     Document Type: Article

References (7)

1. Arrambide K, Toto RD. Tumor lysis syndrome. Semin. Nephrol. 1993; 13: 273-80.
2. Baeksgaard L, Sorensen JB. Acute tumor lysis syndrome in solid tumors - a case report and review of the literature. Cancer Chemother. Pharmacol. 2003; 51: 187-92.
3. Tanvetyanon T, Choudhury AM. Fatal acute tumor lysis syndrome, hepatic encephalopathy and flare phenomenon following combined androgen blockade. J. Urol. 2004; 171: 1627.
4. Sorscher SM. Tumor lysis syndrome following docetaxel therapy for extensive metastatic prostate cancer. Cancer Chemother. Pharmacol. 2004; 54: 191-2.
5. Tannock IF, de Wit R, Berry WR et al. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N. Engl. J. Med. 2004; 351: 1502-12.
6. Petrylak DP, Tangen CM, Hussain MH et al. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. N. Engl. J. Med. 2004; 351: 1513-20.
7. Beer TM, Lemmon D, Lowe BA, Henner WD. High-dose weekly oral calcitriol in patients with a rising PSA after prostatectomy or radiation for prostate carcinoma. Cancer 2003; 97: 1217-24.